GSK (ADR)
Develops specialty medicines and vaccines through immune-system science and advanced technologies.
$50.57
After-hours close−0.26 (−0.51%)
At close$50.83(+1.11%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $1.37 | — | — |
| Jul 2026 | $1.27 | $1.36 | +7.1% |
| Jul 2026 | $1.27 | $1.36 | +7.1% |
| Apr 2026 | $1.16 | $1.24 | +6.9% |
| Feb 2026 | $0.64 | $0.68 | +6.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Oct 2025 | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Jan 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | $1.37 | — | — | $11.88B | — | — |
| Jul 29, 2026 | $1.27 | $1.36 | +7.1% | $11.05B | $11.18B | +1.1% |
| Jul 28, 2026 | $1.27 | $1.36 | +7.1% | $11.02B | $11.18B | +1.4% |
| Apr 29, 2026 | $1.16 | $1.24 | +6.9% | $10.23B | $10.30B | +0.7% |
| Feb 4, 2026 | $0.64 | $0.68 | +6.3% | $11.41B | $11.78B | +3.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Oct 29, 2025 | ||||||
| Jul 30, 2025 | ||||||
| Apr 30, 2025 | ||||||
| Feb 5, 2025 | ||||||
| Oct 30, 2024 | ||||||
| Jul 31, 2024 | ||||||
| Jan 31, 2024 | ||||||
| Nov 1, 2023 | ||||||
| Jul 26, 2023 | ||||||
| Apr 26, 2023 | ||||||
| Feb 1, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Jul 27, 2022 | ||||||
| Apr 27, 2022 | ||||||
| Feb 9, 2022 | ||||||
| Oct 27, 2021 | ||||||
| Jul 28, 2021 | ||||||
| Apr 28, 2021 | ||||||
| Feb 3, 2021 | ||||||
| Oct 28, 2020 | ||||||
| Jul 29, 2020 | ||||||
| Apr 29, 2020 | ||||||
| Feb 5, 2020 | ||||||
| Oct 30, 2019 | ||||||
| Jul 24, 2019 | ||||||
| May 1, 2019 | ||||||
| Feb 6, 2019 | ||||||
| Oct 31, 2018 | ||||||
| Jul 25, 2018 | ||||||
| Apr 25, 2018 | ||||||
| Feb 7, 2018 | ||||||
| Oct 25, 2017 | ||||||
| Jul 26, 2017 | ||||||
| Apr 26, 2017 | ||||||
| Feb 8, 2017 | ||||||
| Oct 26, 2016 | ||||||
| Jul 27, 2016 | ||||||
| Apr 27, 2016 | ||||||
| Feb 3, 2016 | ||||||
| Oct 28, 2015 | ||||||
| Jul 29, 2015 | ||||||